ARCHIVES

In Brief: Adamson’s Appointment Official As DCCP Director; NCI Holds Current Spending To 12 Percent Level

This article is from The Cancer Letter archive.

Vol. 07 No. 43 | October 23, 1981

Download PDF Visit The Full Archive

Related Articles

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

NCA Approves Draft of New Outstanding Investigator Grants

February 10, 1984